> top > docs > PMC:7241115 > annotations

PMC:7241115 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 916-919 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T2 1256-1259 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T3 1505-1508 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T4 1889-1892 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T5 2247-2250 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T6 3391-3394 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T7 4191-4194 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T8 4814-4819 Body_part denotes chest http://purl.org/sig/ont/fma/fma9576
T9 4902-4919 Body_part denotes respiratory tract http://purl.org/sig/ont/fma/fma265130
T10 4947-4952 Body_part denotes chest http://purl.org/sig/ont/fma/fma9576
T11 5251-5256 Body_part denotes chest http://purl.org/sig/ont/fma/fma9576
T12 5445-5450 Body_part denotes organ http://purl.org/sig/ont/fma/fma67498
T13 6712-6718 Body_part denotes throat http://purl.org/sig/ont/fma/fma228738
T14 6793-6796 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T15 7099-7105 Body_part denotes throat http://purl.org/sig/ont/fma/fma228738
T16 8228-8231 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T17 8309-8312 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T18 8503-8506 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T19 8556-8559 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T20 8581-8587 Body_part denotes throat http://purl.org/sig/ont/fma/fma228738
T21 9000-9003 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T22 9095-9098 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T23 9193-9196 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T24 9588-9591 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T25 9889-9892 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T26 9994-10000 Body_part denotes throat http://purl.org/sig/ont/fma/fma228738
T27 10606-10610 Body_part denotes body http://purl.org/sig/ont/fma/fma256135
T28 11551-11567 Body_part denotes White blood cell http://purl.org/sig/ont/fma/fma62852
T29 11563-11567 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T30 11713-11723 Body_part denotes Lymphocyte http://purl.org/sig/ont/fma/fma62863
T31 11811-11819 Body_part denotes Platelet http://purl.org/sig/ont/fma/fma62851
T32 12958-12963 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T33 13001-13006 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T34 13167-13170 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T35 13264-13267 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T36 13443-13446 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T37 13539-13542 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T38 13866-13869 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T39 13936-13939 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T40 14139-14142 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T41 14295-14299 Body_part denotes body http://purl.org/sig/ont/fma/fma256135
T42 14937-14940 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T43 15196-15199 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T44 15885-15888 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T45 16079-16082 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T46 16478-16488 Body_part denotes lymphocyte http://purl.org/sig/ont/fma/fma62863
T47 17229-17232 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T48 18321-18337 Body_part denotes White blood cell http://purl.org/sig/ont/fma/fma62852
T49 18333-18337 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T50 18438-18448 Body_part denotes Lymphocyte http://purl.org/sig/ont/fma/fma62863
T51 18507-18515 Body_part denotes Platelet http://purl.org/sig/ont/fma/fma62851
T52 19209-19214 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T53 19252-19257 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T54 19451-19454 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T55 20339-20342 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T56 20535-20538 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T57 20627-20630 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T58 20726-20729 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T59 20886-20892 Body_part denotes throat http://purl.org/sig/ont/fma/fma228738
T60 20976-20979 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T61 21247-21250 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T62 21350-21353 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T63 21610-21613 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T64 21938-21941 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T65 22265-22268 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T66 22613-22627 Body_part denotes interleukin-18 http://purl.org/sig/ont/fma/fma264821
T67 22629-22640 Body_part denotes interleukin http://purl.org/sig/ont/fma/fma86578
T68 22664-22671 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T69 22966-22969 Body_part denotes HIV http://purl.org/sig/ont/fma/fma278683
T70 23388-23391 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T71 23782-23785 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T72 25615-25618 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T73 25951-25954 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T74 26097-26100 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T75 26216-26219 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T76 26805-26808 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T77 26900-26903 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 4814-4819 Body_part denotes chest http://purl.obolibrary.org/obo/UBERON_0001443
T2 4902-4919 Body_part denotes respiratory tract http://purl.obolibrary.org/obo/UBERON_0000065
T3 4947-4952 Body_part denotes chest http://purl.obolibrary.org/obo/UBERON_0001443
T4 5251-5256 Body_part denotes chest http://purl.obolibrary.org/obo/UBERON_0001443
T5 5445-5450 Body_part denotes organ http://purl.obolibrary.org/obo/UBERON_0000062
T6 6712-6718 Body_part denotes throat http://purl.obolibrary.org/obo/UBERON_0000341
T7 7099-7105 Body_part denotes throat http://purl.obolibrary.org/obo/UBERON_0000341
T8 8581-8587 Body_part denotes throat http://purl.obolibrary.org/obo/UBERON_0000341
T9 9994-10000 Body_part denotes throat http://purl.obolibrary.org/obo/UBERON_0000341
T10 11557-11562 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T11 12958-12963 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T12 13001-13006 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T13 18327-18332 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T14 19209-19214 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T15 19252-19257 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T16 20886-20892 Body_part denotes throat http://purl.obolibrary.org/obo/UBERON_0000341
T17 26534-26539 Body_part denotes scale http://purl.obolibrary.org/obo/UBERON_0002542

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 142-150 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T2 153-162 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T3 219-227 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T4 230-239 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T5 471-518 Disease denotes severe acute respiratory syndrome coronavirus 2 http://purl.obolibrary.org/obo/MONDO_0100096
T6 471-504 Disease denotes severe acute respiratory syndrome http://purl.obolibrary.org/obo/MONDO_0005091
T7 520-528 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T8 659-667 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T9 905-913 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T10 1245-1253 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T11 1494-1502 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T12 1878-1886 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T13 1919-1943 Disease denotes coronavirus disease 2019 http://purl.obolibrary.org/obo/MONDO_0100096
T14 1945-1953 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T15 2065-2073 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T16 2236-2244 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T17 2298-2345 Disease denotes Severe acute respiratory syndrome coronavirus 2 http://purl.obolibrary.org/obo/MONDO_0100096
T18 2347-2355 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T19 2502-2526 Disease denotes coronavirus disease 2019 http://purl.obolibrary.org/obo/MONDO_0100096
T20 2528-2536 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T21 2780-2788 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T22 3108-3116 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T23 3380-3388 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T24 3773-3781 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T25 3784-3793 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T26 4032-4040 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T27 4152-4160 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T28 4163-4172 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T29 4532-4541 Disease denotes Infection http://purl.obolibrary.org/obo/MONDO_0005550
T30 4657-4665 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T31 4801-4810 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T32 4934-4943 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T33 5353-5372 Disease denotes respiratory failure http://purl.obolibrary.org/obo/MONDO_0021113
T34 6382-6390 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T35 6393-6402 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T36 6782-6790 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T37 7050-7058 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T38 7627-7635 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T39 8217-8225 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T40 8298-8306 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T41 8492-8500 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T42 8791-8799 Disease denotes diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T43 8801-8813 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T44 8818-8833 Disease denotes cardiac disease http://purl.obolibrary.org/obo/MONDO_0005267
T45 8989-8997 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T46 9084-9092 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T47 9182-9190 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T48 9577-9585 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T49 9878-9886 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T50 10245-10257 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T51 10272-10280 Disease denotes diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T52 10297-10312 Disease denotes cardiac disease http://purl.obolibrary.org/obo/MONDO_0005267
T53 10443-10451 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T54 10823-10831 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T55 10834-10843 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T56 11086-11098 Disease denotes Hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T57 11135-11143 Disease denotes Diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T58 11176-11191 Disease denotes Cardiac disease http://purl.obolibrary.org/obo/MONDO_0005267
T59 11223-11229 Disease denotes Stroke http://purl.obolibrary.org/obo/MONDO_0005098|http://purl.obolibrary.org/obo/MONDO_0011057
T61 11260-11264 Disease denotes COPD http://purl.obolibrary.org/obo/MONDO_0005002
T62 11268-11274 Disease denotes asthma http://purl.obolibrary.org/obo/MONDO_0004979
T63 11298-11325 Disease denotes Chronic renal insufficiency http://purl.obolibrary.org/obo/MONDO_0005300
T64 11306-11325 Disease denotes renal insufficiency http://purl.obolibrary.org/obo/MONDO_0001106
T65 12947-12971 Disease denotes congestive heart disease http://purl.obolibrary.org/obo/MONDO_0005009
T66 12958-12971 Disease denotes heart disease http://purl.obolibrary.org/obo/MONDO_0005267
T67 13001-13014 Disease denotes heart disease http://purl.obolibrary.org/obo/MONDO_0005267
T68 13156-13164 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T69 13253-13261 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T70 13432-13440 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T71 13528-13536 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T72 13612-13620 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T73 13855-13863 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T74 13925-13933 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T75 14599-14607 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T76 14708-14720 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T77 14722-14730 Disease denotes diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T78 14735-14750 Disease denotes cardiac disease http://purl.obolibrary.org/obo/MONDO_0005267
T79 14926-14934 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T80 15185-15193 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T81 15559-15571 Disease denotes Hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T82 15595-15610 Disease denotes Cardiac disease http://purl.obolibrary.org/obo/MONDO_0005267
T83 15634-15642 Disease denotes Diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T84 15874-15882 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T85 16068-16076 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T86 16421-16429 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T87 16888-16896 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T88 17218-17226 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T89 17665-17673 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T90 17676-17685 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T91 17934-17946 Disease denotes Hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T92 17973-17981 Disease denotes Diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T93 18005-18020 Disease denotes Cardiac disease http://purl.obolibrary.org/obo/MONDO_0005267
T94 18044-18050 Disease denotes Stroke http://purl.obolibrary.org/obo/MONDO_0005098|http://purl.obolibrary.org/obo/MONDO_0011057
T96 18073-18077 Disease denotes COPD http://purl.obolibrary.org/obo/MONDO_0005002
T97 18081-18087 Disease denotes asthma http://purl.obolibrary.org/obo/MONDO_0004979
T98 18110-18137 Disease denotes Chronic renal insufficiency http://purl.obolibrary.org/obo/MONDO_0005300
T99 18118-18137 Disease denotes renal insufficiency http://purl.obolibrary.org/obo/MONDO_0001106
T100 19198-19222 Disease denotes congestive heart disease http://purl.obolibrary.org/obo/MONDO_0005009
T101 19209-19222 Disease denotes heart disease http://purl.obolibrary.org/obo/MONDO_0005267
T102 19252-19265 Disease denotes heart disease http://purl.obolibrary.org/obo/MONDO_0005267
T103 19440-19448 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T104 19935-19943 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T105 20019-20027 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T106 20328-20336 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T107 20524-20532 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T108 20616-20624 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T109 20715-20723 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T110 20965-20973 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T111 21339-21347 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T112 21522-21530 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T113 21599-21607 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T114 21675-21684 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T115 21927-21935 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T116 22016-22024 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T117 22027-22036 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T118 22099-22134 Disease denotes acute respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0006502
T119 22105-22134 Disease denotes respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0009971
T120 22254-22262 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T121 22529-22537 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T122 22888-22904 Disease denotes viral infections http://purl.obolibrary.org/obo/MONDO_0005108
T123 22942-22950 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T124 23154-23162 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T125 23377-23385 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T126 23437-23445 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T127 23771-23779 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T128 24046-24054 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T129 24441-24450 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T130 24596-24604 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T131 24691-24699 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T132 24759-24767 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T133 24828-24837 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T134 25204-25213 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T135 25488-25496 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T136 25604-25612 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T137 25667-25677 Disease denotes infectious http://purl.obolibrary.org/obo/MONDO_0005550
T138 25805-25813 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T139 25940-25948 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T140 26205-26213 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T141 26705-26713 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T142 26794-26802 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T143 26889-26897 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T144 27027-27035 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T145 27499-27518 Disease denotes Respiratory Disease http://purl.obolibrary.org/obo/MONDO_0005087
T146 27561-27580 Disease denotes Respiratory Disease http://purl.obolibrary.org/obo/MONDO_0005087

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 1154-1156 http://purl.obolibrary.org/obo/CLO_0001407 denotes 52
T2 1168-1170 http://purl.obolibrary.org/obo/CLO_0053799 denotes 45
T3 1178-1182 http://purl.obolibrary.org/obo/UBERON_0003101 denotes male
T4 1178-1182 http://www.ebi.ac.uk/efo/EFO_0000970 denotes male
T5 1322-1324 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T6 1620-1622 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T7 2359-2362 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T8 2538-2541 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T9 2565-2568 http://purl.obolibrary.org/obo/CLO_0050509 denotes 2–7
T10 2645-2648 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T11 2874-2875 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T12 3131-3132 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T13 4386-4387 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T14 4467-4479 http://purl.obolibrary.org/obo/OBI_0000245 denotes Organization
T15 4814-4819 http://www.ebi.ac.uk/efo/EFO_0000965 denotes chest
T16 4947-4952 http://www.ebi.ac.uk/efo/EFO_0000965 denotes chest
T17 5125-5133 http://purl.obolibrary.org/obo/UBERON_0001637 denotes arterial
T18 5125-5133 http://www.ebi.ac.uk/efo/EFO_0000814 denotes arterial
T19 5243-5245 http://purl.obolibrary.org/obo/CLO_0001382 denotes 48
T20 5251-5256 http://www.ebi.ac.uk/efo/EFO_0000965 denotes chest
T21 5445-5450 http://purl.obolibrary.org/obo/UBERON_0003103 denotes organ
T22 6492-6493 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T23 7257-7258 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T24 7923-7927 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T25 7946-7950 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T26 8009-8013 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T27 8030-8034 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T28 8365-8366 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T29 8643-8644 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T30 8654-8658 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T31 8916-8917 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T32 9294-9296 http://purl.obolibrary.org/obo/CLO_0009877 denotes NY
T33 9304-9305 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T34 9310-9316 http://purl.obolibrary.org/obo/UBERON_0002415 denotes tailed
T35 9520-9521 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T36 9531-9533 http://purl.obolibrary.org/obo/CLO_0001382 denotes 48
T37 9557-9563 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T38 9763-9765 http://purl.obolibrary.org/obo/CLO_0002857 denotes E1
T39 9862-9863 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T40 9969-9975 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T41 10137-10139 http://purl.obolibrary.org/obo/CLO_0001407 denotes 52
T42 10160-10162 http://purl.obolibrary.org/obo/CLO_0053799 denotes 45
T43 10170-10174 http://purl.obolibrary.org/obo/UBERON_0003101 denotes male
T44 10170-10174 http://www.ebi.ac.uk/efo/EFO_0000970 denotes male
T45 10480-10482 http://purl.obolibrary.org/obo/CLO_0053799 denotes 45
T46 10948-10950 http://purl.obolibrary.org/obo/CLO_0001407 denotes 52
T47 10952-10954 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T48 10959-10961 http://purl.obolibrary.org/obo/CLO_0001382 denotes 48
T49 10986-10990 http://purl.obolibrary.org/obo/UBERON_0003101 denotes Male
T50 10986-10990 http://www.ebi.ac.uk/efo/EFO_0000970 denotes Male
T51 10999-11001 http://purl.obolibrary.org/obo/CLO_0053799 denotes 45
T52 11426-11428 http://purl.obolibrary.org/obo/CLO_0001382 denotes 48
T53 11436-11438 http://purl.obolibrary.org/obo/CLO_0053794 denotes 41
T54 11557-11562 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T55 11563-11567 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T56 11616-11618 http://purl.obolibrary.org/obo/CLO_0050509 denotes 27
T57 11636-11638 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T58 11785-11787 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T59 11795-11797 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T60 11926-11928 http://purl.obolibrary.org/obo/CLO_0001407 denotes 52
T61 12179-12182 http://purl.obolibrary.org/obo/CLO_0054060 denotes 102
T62 12190-12192 http://purl.obolibrary.org/obo/CLO_0001407 denotes 52
T63 12274-12276 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T64 12435-12437 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T65 12442-12444 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T66 12535-12539 http://purl.obolibrary.org/obo/CLO_0001405 denotes 5–11
T67 12607-12612 http://purl.obolibrary.org/obo/CLO_0001009 denotes 12–21
T68 12620-12622 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T69 12623-12625 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T70 12697-12699 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T71 12701-12703 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T72 12958-12963 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T73 12958-12963 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T74 12958-12963 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T75 12958-12963 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T76 13001-13006 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T77 13001-13006 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T78 13001-13006 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T79 13001-13006 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T80 13197-13199 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T81 13295-13301 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T82 13342-13348 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T83 13487-13488 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T84 13911-13912 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T85 14172-14173 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T86 14269-14270 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T87 14652-14654 http://purl.obolibrary.org/obo/CLO_0002860 denotes E2
T88 14886-14888 http://purl.obolibrary.org/obo/CLO_0002860 denotes E2
T89 14999-15000 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T90 15053-15055 http://purl.obolibrary.org/obo/CLO_0002861 denotes E3
T91 15083-15085 http://purl.obolibrary.org/obo/CLO_0002857 denotes E1
T92 15090-15092 http://purl.obolibrary.org/obo/CLO_0002860 denotes E2
T93 15454-15458 http://purl.obolibrary.org/obo/UBERON_0003101 denotes Male
T94 15454-15458 http://www.ebi.ac.uk/efo/EFO_0000970 denotes Male
T95 16434-16435 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T96 16476-16477 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T97 16586-16587 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T98 16941-16943 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T99 16954-16956 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T100 17116-17118 http://purl.obolibrary.org/obo/CLO_0002861 denotes E3
T101 17196-17197 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T102 17825-17827 http://purl.obolibrary.org/obo/CLO_0001302 denotes 34
T103 17850-17854 http://purl.obolibrary.org/obo/UBERON_0003101 denotes Male
T104 17850-17854 http://www.ebi.ac.uk/efo/EFO_0000970 denotes Male
T105 17859-17861 http://purl.obolibrary.org/obo/CLO_0001000 denotes 35
T106 18226-18228 http://purl.obolibrary.org/obo/CLO_0001313 denotes 36
T107 18327-18332 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T108 18333-18337 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T109 18369-18371 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T110 18971-18973 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T111 18975-18977 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T112 19039-19041 http://purl.obolibrary.org/obo/CLO_0050509 denotes 27
T113 19209-19214 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T114 19209-19214 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T115 19209-19214 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T116 19209-19214 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T117 19252-19257 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T118 19252-19257 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T119 19252-19257 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T120 19252-19257 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T121 19564-19565 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T122 19636-19637 http://purl.obolibrary.org/obo/CLO_0001021 denotes b
T123 19731-19734 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T124 19757-19758 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T125 20595-20596 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T126 20658-20659 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T127 20749-20750 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T128 21087-21088 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T129 21287-21289 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T130 21580-21581 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T131 21646-21647 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T132 21998-21999 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T133 22041-22044 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T134 22066-22067 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T135 22509-22510 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T136 22538-22541 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T137 22573-22578 http://purl.obolibrary.org/obo/OGG_0000000002 denotes genes
T138 22625-22627 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T139 23097-23100 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T140 23230-23239 http://purl.obolibrary.org/obo/NCBITaxon_38020 denotes marmosets
T141 23254-23256 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T142 23269-23272 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T143 23829-23830 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T144 24068-24069 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T145 24119-24120 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T146 25316-25320 http://purl.obolibrary.org/obo/UBERON_0000473 denotes test
T147 25559-25562 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T148 25678-25683 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T149 26646-26653 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T150 27169-27172 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T151 27732-27735 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T152 27868-27871 http://purl.obolibrary.org/obo/CLO_0002040 denotes B-T
T153 27873-27876 http://purl.obolibrary.org/obo/CLO_0002697 denotes Dan
T154 28245-28248 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T155 28301-28304 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T156 28357-28360 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T157 28413-28416 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T158 28460-28463 http://purl.obolibrary.org/obo/CLO_0002040 denotes B-T
T159 28465-28468 http://purl.obolibrary.org/obo/CLO_0002697 denotes Dan
T160 28469-28472 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T161 28527-28530 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T162 28583-28586 http://purl.obolibrary.org/obo/CLO_0051582 denotes has

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 63-82 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T2 63-72 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T3 73-82 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T4 163-172 Chemical denotes Lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T5 173-182 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T6 364-373 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T7 550-569 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T8 550-559 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T9 560-569 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T10 1178-1182 Chemical denotes male http://purl.obolibrary.org/obo/CHEBI_30780
T11 2119-2138 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T12 2119-2128 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T13 2129-2138 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T14 2176-2195 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T15 2176-2185 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T16 2186-2195 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T17 2743-2752 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T18 2923-2942 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T19 2923-2932 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T20 2933-2942 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T21 5076-5082 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805
T22 5134-5140 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805
T23 5168-5174 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805
T24 6167-6170 Chemical denotes Y-H http://purl.obolibrary.org/obo/CHEBI_73695
T25 6624-6632 Chemical denotes reagents http://purl.obolibrary.org/obo/CHEBI_33893
T26 7235-7253 Chemical denotes methylprednisolone http://purl.obolibrary.org/obo/CHEBI_6888
T27 7316-7325 Chemical denotes Lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T28 7326-7335 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T29 8836-8850 Chemical denotes corticosteroid http://purl.obolibrary.org/obo/CHEBI_50858
T30 9294-9296 Chemical denotes NY http://purl.obolibrary.org/obo/CHEBI_73427
T31 10170-10174 Chemical denotes male http://purl.obolibrary.org/obo/CHEBI_30780
T32 10503-10517 Chemical denotes corticosteroid http://purl.obolibrary.org/obo/CHEBI_50858
T33 11896-11906 Chemical denotes Creatinine http://purl.obolibrary.org/obo/CHEBI_16737
T34 11963-11966 Chemical denotes AST http://purl.obolibrary.org/obo/CHEBI_76649
T35 12103-12112 Chemical denotes Lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T36 12113-12122 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T37 12239-12245 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805
T38 12802-12805 Chemical denotes AST http://purl.obolibrary.org/obo/CHEBI_76649
T39 12807-12816 Chemical denotes aspartate http://purl.obolibrary.org/obo/CHEBI_132943|http://purl.obolibrary.org/obo/CHEBI_29995|http://purl.obolibrary.org/obo/CHEBI_72314
T42 14787-14802 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T43 15750-15769 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T44 15750-15759 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T45 15760-15769 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T46 16118-16137 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T47 16118-16127 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T48 16128-16137 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T49 16931-16936 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T50 17016-17021 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T51 17708-17727 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T52 17708-17717 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T53 17718-17727 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T54 18570-18580 Chemical denotes Creatinine http://purl.obolibrary.org/obo/CHEBI_16737
T55 18625-18628 Chemical denotes AST http://purl.obolibrary.org/obo/CHEBI_76649
T56 18795-18801 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805
T57 19153-19156 Chemical denotes AST http://purl.obolibrary.org/obo/CHEBI_76649
T58 19158-19167 Chemical denotes aspartate http://purl.obolibrary.org/obo/CHEBI_132943|http://purl.obolibrary.org/obo/CHEBI_29995|http://purl.obolibrary.org/obo/CHEBI_72314
T61 19318-19337 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T62 19318-19327 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T63 19328-19337 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T64 19521-19540 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T65 19521-19530 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T66 19531-19540 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T67 19898-19907 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T68 20412-20426 Chemical denotes corticosteroid http://purl.obolibrary.org/obo/CHEBI_50858
T69 22664-22671 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T70 22952-22961 Chemical denotes Lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T71 22972-22990 Chemical denotes protease inhibitor http://purl.obolibrary.org/obo/CHEBI_37670|http://purl.obolibrary.org/obo/CHEBI_60258
T73 22981-22990 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T74 23029-23038 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T75 23051-23055 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T76 23075-23084 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T77 24243-24252 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T78 24501-24506 Chemical denotes group http://purl.obolibrary.org/obo/CHEBI_24433
T79 24794-24817 Chemical denotes neuraminidase inhibitor http://purl.obolibrary.org/obo/CHEBI_52425
T80 24808-24817 Chemical denotes inhibitor http://purl.obolibrary.org/obo/CHEBI_35222
T81 26668-26682 Chemical denotes corticosteroid http://purl.obolibrary.org/obo/CHEBI_50858
T82 27816-27819 Chemical denotes Y-H http://purl.obolibrary.org/obo/CHEBI_73695
T83 27910-27913 Chemical denotes Y-H http://purl.obolibrary.org/obo/CHEBI_73695
T84 27920-27923 Chemical denotes Y-N http://purl.obolibrary.org/obo/CHEBI_141452
T85 27986-27989 Chemical denotes Y-H http://purl.obolibrary.org/obo/CHEBI_73695
T86 28004-28007 Chemical denotes Y-N http://purl.obolibrary.org/obo/CHEBI_141452
T87 28348-28351 Chemical denotes Y-N http://purl.obolibrary.org/obo/CHEBI_141452
T88 28574-28577 Chemical denotes Y-H http://purl.obolibrary.org/obo/CHEBI_73695

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 34-48 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T2 277-291 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T3 591-605 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T4 733-754 http://purl.obolibrary.org/obo/GO_0001171 denotes reverse transcription
T5 741-754 http://purl.obolibrary.org/obo/GO_0006351 denotes transcription
T6 1093-1107 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T7 1658-1672 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T8 2012-2026 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T9 2623-2637 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T10 2843-2857 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T11 3049-3063 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T12 3512-3526 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T13 3605-3619 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T14 3709-3723 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T15 4240-4254 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T16 5105-5114 http://purl.obolibrary.org/obo/GO_0007585 denotes breathing
T17 6504-6525 http://purl.obolibrary.org/obo/GO_0001171 denotes reverse transcription
T18 6512-6525 http://purl.obolibrary.org/obo/GO_0006351 denotes transcription
T19 6959-6973 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T20 8252-8266 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T21 8406-8420 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T22 8716-8730 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T23 12411-12425 http://purl.obolibrary.org/obo/GO_0019076 denotes Viral shedding
T24 12901-12915 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T25 13101-13115 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T26 14005-14019 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T27 14074-14088 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T28 14838-14852 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T29 17388-17402 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T30 18951-18965 http://purl.obolibrary.org/obo/GO_0019076 denotes Viral shedding
T31 19716-19730 http://purl.obolibrary.org/obo/GO_0019076 denotes Viral shedding
T32 19835-19849 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T33 20158-20172 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T34 20450-20464 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T35 21449-21463 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T36 22375-22400 http://purl.obolibrary.org/obo/GO_0002250 denotes adaptive immune responses
T37 22475-22489 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T38 22591-22606 http://purl.obolibrary.org/obo/GO_0045087 denotes innate immunity
T39 22888-22904 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infections
T40 23511-23525 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T41 23957-23971 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T42 24867-24881 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T43 25054-25079 http://purl.obolibrary.org/obo/GO_1903901 denotes inhibit viral replication
T44 25062-25079 http://purl.obolibrary.org/obo/GO_0019079 denotes viral replication
T45 25062-25079 http://purl.obolibrary.org/obo/GO_0019058 denotes viral replication
T46 25401-25415 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T47 26300-26314 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T48 26351-26365 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding
T49 26620-26634 http://purl.obolibrary.org/obo/GO_0019076 denotes viral shedding

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 4801-4810 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T2 4892-4897 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T3 4934-4943 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T4 5353-5372 Phenotype denotes respiratory failure http://purl.obolibrary.org/obo/HP_0002878
T5 5425-5430 Phenotype denotes shock http://purl.obolibrary.org/obo/HP_0031273
T6 6865-6870 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T7 6872-6877 Phenotype denotes cough http://purl.obolibrary.org/obo/HP_0012735
T8 6882-6890 Phenotype denotes dyspnoea http://purl.obolibrary.org/obo/HP_0002094
T9 8801-8813 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T10 10245-10257 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T11 11086-11098 Phenotype denotes Hypertension http://purl.obolibrary.org/obo/HP_0000822
T12 11223-11229 Phenotype denotes Stroke http://purl.obolibrary.org/obo/HP_0001297
T13 11260-11264 Phenotype denotes COPD http://purl.obolibrary.org/obo/HP_0006510
T14 11268-11274 Phenotype denotes asthma http://purl.obolibrary.org/obo/HP_0002099
T15 11306-11325 Phenotype denotes renal insufficiency http://purl.obolibrary.org/obo/HP_0000083
T16 14708-14720 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T17 15559-15571 Phenotype denotes Hypertension http://purl.obolibrary.org/obo/HP_0000822
T18 17934-17946 Phenotype denotes Hypertension http://purl.obolibrary.org/obo/HP_0000822
T19 18044-18050 Phenotype denotes Stroke http://purl.obolibrary.org/obo/HP_0001297
T20 18073-18077 Phenotype denotes COPD http://purl.obolibrary.org/obo/HP_0006510
T21 18081-18087 Phenotype denotes asthma http://purl.obolibrary.org/obo/HP_0002099
T22 18118-18137 Phenotype denotes renal insufficiency http://purl.obolibrary.org/obo/HP_0000083
T23 22105-22125 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-162 Sentence denotes Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection
T2 163-239 Sentence denotes Lopinavir/ritonavir in non-critically ill patients with SARS-CoV-2 infection
T3 241-249 Sentence denotes Abstract
T4 250-260 Sentence denotes Background
T5 261-384 Sentence denotes The duration of viral shedding is central to the guidance of decisions about isolation precautions and antiviral treatment.
T6 385-620 Sentence denotes However, studies regarding the risk factors associated with prolonged shedding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the impact of lopinavir/ritonavir (LPV/r) treatment on viral shedding remain scarce.
T7 622-629 Sentence denotes Methods
T8 630-780 Sentence denotes Data were collected from all SARS-CoV-2 infected patients who were admitted to isolation wards and had reverse transcription PCR conversion at the No.
T9 781-863 Sentence denotes 3 People's Hospital of Hubei province, China, between 31 January and 9 March 2020.
T10 864-995 Sentence denotes We compared clinical characteristics and SARS-CoV-2 RNA shedding between patients initiated with LPV/r treatment and those without.
T11 996-1108 Sentence denotes Logistic regression analysis was employed to evaluate the risk factors associated with prolonged viral shedding.
T12 1110-1117 Sentence denotes Results
T13 1118-1221 Sentence denotes Of 120 patients, the median age was 52 years, 54 (45%) were male and 78 (65%) received LPV/r treatment.
T14 1222-1334 Sentence denotes The median duration of SARS-CoV-2 RNA detection from symptom onset was 23 days (interquartile range 18–32 days).
T15 1335-1518 Sentence denotes Older age (OR 1.03, 95% CI 1.00–1.05; p=0.03) and the lack of LPV/r treatment (OR 2.42, 95% CI 1.10–5.36; p=0.029) were independent risk factors for prolonged SARS-CoV-2 RNA shedding.
T16 1519-1778 Sentence denotes Patients who initiated LPV/r treatment within 10 days from symptom onset, but not initiated from day 11 onwards, had significantly shorter viral shedding duration compared with those without LPV/r treatment (median 19 days versus 28.5 days; log-rank p<0.001).
T17 1780-1790 Sentence denotes Conclusion
T18 1791-1955 Sentence denotes Older age and the lack of LPV/r treatment were independently associated with prolonged SARS-CoV-2 RNA shedding in patients with coronavirus disease 2019 (COVID-19).
T19 1956-2036 Sentence denotes Earlier administration of LPV/r treatment could shorten viral shedding duration.
T20 2038-2149 Sentence denotes Risk factors for prolonged SARS-CoV-2 shedding include older age and the lack of lopinavir/ritonavir treatment.
T21 2150-2283 Sentence denotes Earlier administration of lopinavir/ritonavir treatment could shorten the duration of SARS-CoV-2 RNA shedding. https://bit.ly/2LxskI9
T22 2285-2297 Sentence denotes Introduction
T23 2298-2422 Sentence denotes Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused substantial morbidity and mortality worldwide [1–5].
T24 2423-2570 Sentence denotes The evidence pertaining to the epidemiological and clinical characteristics of coronavirus disease 2019 (COVID-19) has been emerging rapidly [2–7].
T25 2571-2796 Sentence denotes However, few studies have evaluated the duration of viral shedding, which has important implications for guiding the clinical decisions regarding isolation precautions and antiviral treatment in patients with COVID-19 [7, 8].
T26 2797-2873 Sentence denotes Factors associated with prolonged duration of viral shedding remain elusive.
T27 2874-3121 Sentence denotes A recent randomised controlled trial showed that lopinavir/ritonavir (LPV/r) treatment could not provide additional benefits beyond standard-of-care (including in relation to viral shedding) in hospitalised severely ill patients with COVID-19 [9].
T28 3122-3273 Sentence denotes However, a post hoc subgroup analysis found that earlier administration of LPV/r treatment accelerated the clinical recovery and reduced mortality [9].
T29 3274-3527 Sentence denotes Therefore, it remains crucial to determine whether adding LPV/r treatment could influence the duration of SARS-CoV-2 RNA shedding in non-critically ill patients and whether an earlier administration of LPV/r could shorten the duration of viral shedding.
T30 3528-3830 Sentence denotes Thus, this study sought to assess the risk factors associated with prolonged viral shedding and the potential impact of earlier administration of LPV/r treatment on the duration of viral shedding in hospitalised non-critically ill patients with SARS-CoV-2 infection between 31 January and 9 March 2020.
T31 3832-3839 Sentence denotes Methods
T32 3841-3873 Sentence denotes Participants and data collection
T33 3874-3949 Sentence denotes This retrospective study included all patients who were admitted to the No.
T34 3950-4108 Sentence denotes 3 People's Hospital of Hubei province (one of the designated hospitals during the COVID-19 outbreak in Wuhan, China) between 31 January 2020 and 9 March 2020.
T35 4109-4255 Sentence denotes Eligible patients had laboratory-confirmed SARS-CoV-2 infection and had available RNA virological data to estimate the duration of viral shedding.
T36 4256-4570 Sentence denotes Demographic, clinical, laboratory, treatment and successive virological data were extracted from electronic medical records using a standardised data collection sheet that was modified based on the World Health Organization/International Severe Acute Respiratory and Emerging Infection Consortium case record form.
T37 4571-4734 Sentence denotes We assessed the severity of illness according to the Chinese management guideline for COVID-19 (sixth version) [10], and used four classes of severity, as follows.
T38 4735-4828 Sentence denotes 1) “Mild” represented patients with mild clinical symptoms and no pneumonia on chest imaging.
T39 4829-4961 Sentence denotes 2) “General” represented patients with clinical symptoms (i.e. fever and respiratory tract symptoms) and pneumonia on chest imaging.
T40 4962-5265 Sentence denotes 3) “Severe” represented adults who met any of the following criteria: respiratory rate ≥30 breaths·min−1, resting oxygen saturation ≤93% while breathing room air, arterial oxygen tension (PaO2)/inspiratory oxygen fraction (FIO2) ≤300 mmHg, and/or >50% lesion progression within 24–48 h on chest imaging.
T41 5266-5506 Sentence denotes 4) “Critical” represented adults who met any of the following criteria: development of respiratory failure that required mechanical ventilation, occurrence of shock, and/or other organ failure requiring admission to the intensive care unit.
T42 5507-5718 Sentence denotes The duration of temperature recovery was defined as the duration between the date of symptom onset and the date when the patient's axillary temperature returned to 37.3°C or below without an increase thereafter.
T43 5719-5954 Sentence denotes The duration of radiological recovery was defined as the duration between the date of symptom onset and the date when the patient's radiological abnormalities were improved without appearance of new radiological lesions at other sites.
T44 5955-6014 Sentence denotes We also collected the dose and duration of LPV/r treatment.
T45 6015-6065 Sentence denotes All data were double-checked by two physicians (D.
T46 6066-6078 Sentence denotes Yan and X-Y.
T47 6079-6148 Sentence denotes Liu), with any discrepancy being resolved by consensus discussion (D.
T48 6149-6158 Sentence denotes Yan, X-Y.
T49 6159-6171 Sentence denotes Liu and Y-H.
T50 6172-6177 Sentence denotes Gao).
T51 6178-6219 Sentence denotes The institutional review board of the No.
T52 6220-6324 Sentence denotes 3 People's Hospital of Hubei province approved the study, and patient-level informed consent was waived.
T53 6326-6352 Sentence denotes Virological investigations
T54 6353-6447 Sentence denotes Laboratory identification of SARS-CoV-2 infection was made at Wuhan Jinyintan Hospital and No.
T55 6448-6545 Sentence denotes 3 People's Hospital of Hubei province using a real-time reverse transcription PCR (RT-PCR) assay.
T56 6546-6694 Sentence denotes The same methods as previously described were adopted, in which the detection reagents were provided by the local Center for Disease Control [2, 3].
T57 6695-6892 Sentence denotes After admission, throat-swab specimens were collected and sent for the re-detection of SARS-CoV-2 RNA using RT-PCR assays every 2 days after symptom remission (including fever, cough and dyspnoea).
T58 6893-6942 Sentence denotes Quantitative virological data were not available.
T59 6943-7175 Sentence denotes The duration of viral shedding was defined as the interval from the date of symptom onset to the date when SARS-CoV-2 was undetectable from two consecutive throat-swab specimens (≥24 h apart), without converting positive thereafter.
T60 7176-7314 Sentence denotes Corticosteroid treatment referred to the administration of methylprednisolone at a dose equivalent to ≥25 mg·day−1 during hospitalisation.
T61 7316-7345 Sentence denotes Lopinavir/ritonavir treatment
T62 7346-7514 Sentence denotes LPV/r (400 mg and 100 mg, orally, twice daily) was administered to the laboratory-confirmed cases at the discretion of the attending physicians at every isolation ward.
T63 7515-7657 Sentence denotes The treatment duration was ≥10 days, according to the recommendations from the Chinese management guideline for COVID-19 (sixth version) [10].
T64 7658-7736 Sentence denotes Exposure to LPV/r was defined as having received at least one dosage of LPV/r.
T65 7738-7758 Sentence denotes Statistical analysis
T66 7759-7891 Sentence denotes Data are presented as median (interquartile range (IQR)) for continuous variables and number (percentage) for categorical variables.
T67 7892-8073 Sentence denotes We employed the Mann–Whitney U-test or Kruskal–Wallis test for analysis of continuous variables, and the Chi-squared test or Fisher exact test for analysis of categorical variables.
T68 8074-8241 Sentence denotes Univariate and adjusted multivariate logistic regression analyses were used to identify the risk factors associated with prolonged duration of SARS-CoV-2 RNA shedding.
T69 8242-8337 Sentence denotes Prolonged viral shedding was defined as the duration of SARS-CoV-2 RNA shedding being >23 days.
T70 8338-8421 Sentence denotes The cut-off was determined a priori based on the median duration of viral shedding.
T71 8422-8670 Sentence denotes Outcomes were defined as the initial time-point from symptom onset to SARS-CoV-2 RNA assay negativity, which required an undetectable RNA from two consecutive throat-swab specimens (≥24 h apart) and without conversion to a positive test thereafter.
T72 8671-8881 Sentence denotes Variables used for the analysis of prolonged viral shedding included age, sex, smoking status, comorbidities (including diabetes, hypertension and cardiac disease), corticosteroid treatment and LPV/r treatment.
T73 8882-9013 Sentence denotes Analysis was also performed using a Cox proportional hazard model to assess the risk factors for prolonged SARS-CoV-2 RNA shedding.
T74 9014-9207 Sentence denotes We employed Kaplan–Meier survival analysis to estimate the cumulative SARS-CoV-2 RNA-negativity rate and the stratified log-rank statistic to compare the difference in SARS-CoV-2 RNA clearance.
T75 9208-9303 Sentence denotes All statistical analysis was performed using SPSS version 22.0 software (IBM, Armonk, NY, USA).
T76 9304-9376 Sentence denotes A two-tailed p-value of <0.05 was regarded as statistically significant.
T77 9378-9385 Sentence denotes Results
T78 9387-9410 Sentence denotes Patient characteristics
T79 9411-9499 Sentence denotes From 31 January 2020 to 9 March 2020, 168 confirmed cases were admitted to our hospital.
T80 9500-9627 Sentence denotes As of 9 March 2020, a total of 48 patients (28.6%) still tested positive for SARS-CoV-2 RNA and eight patients (4.8%) had died.
T81 9628-9766 Sentence denotes The main characteristics of the patients who were included in and excluded from the final analyses are provided in supplementary table E1.
T82 9767-9826 Sentence denotes There was no notable selection bias between the two groups.
T83 9827-9938 Sentence denotes Thus, 120 patients (71.4%) who had a conversion of SARS-CoV-2 RNA shedding were included in the final analysis.
T84 9939-10007 Sentence denotes All the respiratory specimens tested were derived from throat swabs.
T85 10008-10107 Sentence denotes Table 1 shows the main characteristics of the 120 patients who were included in the final analysis.
T86 10108-10146 Sentence denotes Of these, the median age was 52 years.
T87 10147-10210 Sentence denotes 54 patients (45%) were male, and 12 (10%) were current smokers.
T88 10211-10324 Sentence denotes The common comorbidities included hypertension (32 (26.7%)), diabetes (10 (8.3%)) and cardiac disease (7 (5.8%)).
T89 10325-10466 Sentence denotes 89 patients (74.2%), 30 patients (25%) and one patient (0.8%) were categorised as having general, severe and critical COVID-19, respectively.
T90 10467-10566 Sentence denotes 54 patients (45%) received systemic corticosteroid treatment and 78 (65%) received LPV/r treatment.
T91 10567-10713 Sentence denotes The median duration of recovery of the body temperature and radiological manifestations from illness onset were 10 days and 17 days, respectively.
T92 10714-10764 Sentence denotes The median length of stay in hospital was 21 days.
T93 10765-10852 Sentence denotes TABLE 1 Characteristics of 120 hospitalised patients with SARS-CoV-2 infection in Wuhan
T94 10853-10910 Sentence denotes Characteristic Total patients Days to negativity p-value#
T95 10911-10918 Sentence denotes ≤23 >23
T96 10919-10937 Sentence denotes Patients 120 61 59
T97 10938-10985 Sentence denotes Age years 52 (35–63) 48 (33–60) 56 (42–65) 0.04
T98 10986-11027 Sentence denotes Male sex 54 (45) 30 (49.2) 24 (40.7) 0.35
T99 11028-11072 Sentence denotes Current smoker 12 (10) 5 (8.2) 7 (11.9) 0.50
T100 11073-11084 Sentence denotes Comorbidity
T101 11085-11133 Sentence denotes  Hypertension 32 (26.7) 19 (31.1) 13 (22.0) 0.26
T102 11134-11174 Sentence denotes  Diabetes 10 (8.3) 3 (4.9) 7 (11.9) 0.20
T103 11175-11221 Sentence denotes  Cardiac disease¶ 7 (5.8) 3 (4.9) 4 (6.8) 0.72
T104 11222-11258 Sentence denotes  Stroke 3 (2.5) 1 (1.6) 2 (3.4) 0.62
T105 11259-11296 Sentence denotes  COPD or asthma 2 (1.6) 2 (3.2) 0 (0)
T106 11297-11343 Sentence denotes  Chronic renal insufficiency 1 (0.8) 0 1 (1.7)
T107 11344-11384 Sentence denotes  Malignancy 7 (5.8) 4 (6.6) 3 (5.1) 0.73
T108 11385-11406 Sentence denotes Disease severity 0.36
T109 11407-11445 Sentence denotes  General 89 (74.2) 48 (78.7) 41 (69.5)
T110 11446-11483 Sentence denotes  Severe 30 (25.0) 13 (21.3) 17 (28.8)
T111 11484-11515 Sentence denotes  Critical 1 (0.8) 0 (0) 1 (1.7)
T112 11516-11549 Sentence denotes Laboratory findings on admission+
T113 11550-11610 Sentence denotes  White blood cell count ×109 cells·L−1 5.65 (4.14–7.33) 0.57
T114 11611-11645 Sentence denotes   <4 27 (22.7) 16 (26.7) 11 (18.6)
T115 11646-11680 Sentence denotes   4–10 82 (68.9) 39 (65) 43 (72.9)
T116 11681-11711 Sentence denotes   >10 10 (8.4) 5 (8.3) 5 (8.5)
T117 11712-11767 Sentence denotes  Lymphocyte count ×109 lymphocytes·L−1 1.14 (0.81–1.55)
T118 11768-11809 Sentence denotes   <0.8 29 (24.3) 18 (62.1) 11 (37.9) 0.15
T119 11810-11858 Sentence denotes  Platelet count ×109 platelets·L−1 195 (144–269)
T120 11859-11894 Sentence denotes   <100 7 (5.9) 5 (4.2) 2 (1.0) 0.44
T121 11895-11932 Sentence denotes  Creatinine level μmol·L−1 61 (52–74)
T122 11933-11961 Sentence denotes   >133 4 (3.4) 0 (0) 4 (3.4)
T123 11962-11991 Sentence denotes  AST level U·L−1 31 (24–42.4)
T124 11992-12032 Sentence denotes   >40 33 (27.7) 14 (11.8) 19 (16.0) 0.18
T125 12033-12042 Sentence denotes Treatment
T126 12043-12101 Sentence denotes  Corticosteroid therapy 54 (45.0) 28 (45.9) 26 (44.1) 0.78
T127 12102-12165 Sentence denotes  Lopinavir/ritonavir treatment 78 (65) 46 (75.4) 33 (55.9) 0.02
T128 12166-12214 Sentence denotes  Antibiotics 102 (85.0) 52 (85.2) 50 (84.7) 0.77
T129 12215-12288 Sentence denotes  High-flow nasal canula oxygen therapy 21 (17.5) 10 (16.4) 11 (18.6) 0.88
T130 12289-12346 Sentence denotes  Noninvasive mechanical ventilation 2 (1.7) 0 (0) 2 (3.4)
T131 12347-12401 Sentence denotes  Invasive mechanical ventilation 1 (0.8) 0 (0) 1 (1.7)
T132 12402-12409 Sentence denotes Outcome
T133 12410-12472 Sentence denotes  Viral shedding days 23 (18–32) 18 (15–20.5) 32 (28–38) <0.001
T134 12473-12557 Sentence denotes  Symptom onset to temperature recovery days§ 10 (6–15.5) 7.5 (5–11) 12 (8–20) <0.001
T135 12558-12644 Sentence denotes  Symptom onset to radiological recovery days 17 (12–21) 13.5 (11–18) 20 (12–24) <0.001
T136 12645-12712 Sentence denotes  Hospital length of stay days 21 (17–26) 20 (15–24) 22 (18–28) 0.02
T137 12713-12801 Sentence denotes Data are presented as n, median (interquartile range) or n (%), unless otherwise stated.
T138 12802-13087 Sentence denotes AST: aspartate aminotransferase. #: p-value represents comparisons between patients with prolonged viral shedding and those without; ¶: includes congestive heart disease and coronary atherosclerotic heart disease; +: data were available for 119 patients; §: data were from 99 patients.
T139 13089-13132 Sentence denotes Duration of viral shedding and risk factors
T140 13133-13209 Sentence denotes The median duration of SARS-CoV-2 RNA shedding was 23 days (IQR 18–32 days).
T141 13210-13392 Sentence denotes Only five patients (4.2%) had undetectable SARS-CoV-2 RNA within 10 days, 46 (38.3%) tested negative within 20 days, and 85 (70.8%) tested negative within 30 days from symptom onset.
T142 13393-13588 Sentence denotes Most patients (86.7%) had undetectable SARS-CoV-2 RNA within 37 days after symptom onset, but a subgroup of 12 patients had detectable SARS-CoV-2 RNA up to 40 days after symptom onset (figure 1).
T143 13589-13788 Sentence denotes The median duration of SARS-CoV-2 shedding did not differ significantly among the three groups with different disease severity (general 23 days versus severe 26 days versus critical 28 days; p=0.51).
T144 13789-14020 Sentence denotes FIGURE 1 Distribution of the number of patients with undetectable SARS-CoV-2 RNA by day after symptom onset.In our study, a duration of SARS-CoV-2 RNA shedding of >23 days (above the median) was defined as prolonged viral shedding.
T145 14021-14128 Sentence denotes The main characteristics for patients with prolonged viral shedding and those without are shown in table 1.
T146 14129-14354 Sentence denotes Prolonged RNA shedding was associated with a delayed recovery of radiological manifestations (median 20 days versus 13.5 days; p<0.001) and a delayed recovery of the body temperature (median 12 days versus 7.5 days; p<0.001).
T147 14355-14656 Sentence denotes In the final multivariate logistic model that included all 120 patients, older age (OR 1.03, 95% CI 1.00–1.05; p=0.03) and the lack of LPV/r treatment (OR 2.42, 95% CI 1.10–5.36; p=0.029) were independent risk factors associated with prolonged SARS-CoV-2 shedding (table 2 and supplementary table E2).
T148 14657-14890 Sentence denotes However, comorbidities (including current smoking, hypertension, diabetes and cardiac disease) and the administration of systemic corticosteroids were not associated with prolonged viral shedding (table 2 and supplementary table E2).
T149 14891-15094 Sentence denotes Similar risk factors for prolonged SARS-CoV-2 RNA clearance were observed when the data were analysed using a Cox proportional hazards model (supplementary table E3, and supplementary figures E1 and E2).
T150 15095-15247 Sentence denotes TABLE 2 Multivariable logistic regression analysis of factors associated with duration of SARS-CoV-2 RNA detection in 120 hospitalised patients in Wuhan
T151 15248-15317 Sentence denotes Variable Unadjusted OR (95% CI) p-value Adjusted OR (95% CI) p-value#
T152 15318-15344 Sentence denotes Demographic characteristic
T153 15345-15393 Sentence denotes  Age 1.02 (1.00–1.04) 0.04 1.03 (1.00–1.05) 0.03
T154 15394-15452 Sentence denotes  Age ≥50 years 2.13 (1.02–4.44) 0.04 2.26 (1.07–4.78) 0.03
T155 15453-15506 Sentence denotes  Male sex 0.71 (0.34–1.46) 0.35 0.60 (0.28–1.28) 0.19
T156 15507-15518 Sentence denotes Comorbidity
T157 15519-15557 Sentence denotes  Current smoking 0.86 (0.23–3.18) 0.82
T158 15558-15593 Sentence denotes  Hypertension 0.63 (0.28–1.42) 0.26
T159 15594-15632 Sentence denotes  Cardiac disease 1.41 (0.30–6.57) 0.67
T160 15633-15665 Sentence denotes  Diabetes 2.60 (0.64–10.59) 0.18
T161 15666-15680 Sentence denotes Drug treatment
T162 15681-15740 Sentence denotes  Corticosteroid 0.90 (0.44–1.85) 0.78 0.80 (0.38–1.70) 0.57
T163 15741-15813 Sentence denotes  Lack of lopinavir/ritonavir 2.59 (1.19–5.62) 0.02 2.42 (1.10–5.36) 0.03
T164 15814-15898 Sentence denotes OR >1 indicates that the variable increases the duration of SARS-CoV-2 RNA shedding.
T165 15899-16102 Sentence denotes ORs in multivariable analysis were adjusted for age and sex. #: by use of the logistic regression model, with the cut-off determined according to the median duration of SARS-CoV-2 RNA shedding (23 days).
T166 16104-16147 Sentence denotes The effect of lopinavir/ritonavir treatment
T167 16148-16221 Sentence denotes Of the 120 patients, 78 patients (65%) were administered LPV/r treatment.
T168 16222-16344 Sentence denotes Patients receiving LPV/r treatment and those not receiving LPV/r treatment had similar baseline characteristics (table 3).
T169 16345-16554 Sentence denotes However, patients receiving LPV/r treatment were more likely to have severe COVID-19 and a larger proportion of these patients had a lymphocyte count <0.8×109 cells·L−1, compared those without LPV/r treatment.
T170 16555-16641 Sentence denotes LPV/r therapy was initiated at a median of 10 days (IQR 7–13 days) from symptom onset.
T171 16642-16738 Sentence denotes Figure 2 shows the distribution of time to the initiation of LPV/r treatment from symptom onset.
T172 16739-16806 Sentence denotes The median duration of LPV/r treatment was 10 days (IQR 9–10 days).
T173 16807-16864 Sentence denotes 61 patients (78.2%) received ≥10 days of LRV/r treatment.
T174 16865-17120 Sentence denotes The median duration of SARS-CoV-2 shedding in the LPV/r treatment group was 22 days (IQR 18–29 days), which was significantly shorter than that in the group with no LPV/r treatment (28.5 days, IQR 19.5–38 days; log-rank p=0.009) (supplementary figure E3).
T175 17121-17351 Sentence denotes Patients who initiated LPV/r treatment within 10 days of symptom onset had a shorter duration of SARS-CoV-2 RNA shedding compared with those without LPV/r treatment (median 19 days versus 28.5 days; log-rank p<0.0001) (figure 3a).
T176 17352-17607 Sentence denotes In contrast, the median duration of viral shedding did not differ between patients who initiated LPV/r treatment >10 days from symptom onset and patients who did not receive LPV/r treatment (median 27.5 days versus 28.5 days; log-rank p=0.51) (figure 3b).
T177 17608-17763 Sentence denotes TABLE 3 Comparison of clinical features of patients with SARS-CoV-2 infection who were treated with lopinavir/ritonavir (LPV/r) and without LPV/r, in Wuhan
T178 17764-17795 Sentence denotes Variable LPV/r No LPV/r p-value
T179 17796-17810 Sentence denotes Patients 78 42
T180 17811-17849 Sentence denotes Age years 50 (34–61) 57 (36.5–66) 0.11
T181 17850-17883 Sentence denotes Male sex 35 (44.9) 19 (45.2) 0.83
T182 17884-17920 Sentence denotes Current smoker 8 (10.3) 4 (9.5) 0.74
T183 17921-17932 Sentence denotes Comorbidity
T184 17933-17971 Sentence denotes  Hypertension 19 (24.4) 13 (31.0) 0.39
T185 17972-18003 Sentence denotes  Diabetes 8 (10.3) 2 (4.8) 0.49
T186 18004-18042 Sentence denotes  Cardiac disease# 5 (6.4) 2 (4.8) 1.00
T187 18043-18071 Sentence denotes  Stroke 2 (2.6) 1 (2.4) 1.00
T188 18072-18108 Sentence denotes  COPD or asthma 1 (1.3) 1 (2.4) 0.34
T189 18109-18151 Sentence denotes  Chronic renal insufficiency 1 (1.3) 0 (0)
T190 18152-18184 Sentence denotes  Malignancy 4 (5.1) 3 (7.1) 0.69
T191 18185-18206 Sentence denotes Disease severity 0.02
T192 18207-18235 Sentence denotes  General 53 (67.9) 36 (85.7)
T193 18236-18262 Sentence denotes  Severe 25 (32.1) 5 (11.9)
T194 18263-18286 Sentence denotes  Critical 0 (0) 1 (2.4)
T195 18287-18319 Sentence denotes Laboratory findings on admission
T196 18320-18363 Sentence denotes  White blood cell count ×109 cells·L−1 0.32
T197 18364-18387 Sentence denotes   <4 22 (28.2) 5 (11.9)
T198 18388-18414 Sentence denotes   4–10 49 (62.8) 33 (78.6)
T199 18415-18436 Sentence denotes   >10 7 (9.0) 3 (7.1)
T200 18437-18475 Sentence denotes  Lymphocyte count ×109 lymphocytes·L−1
T201 18476-18505 Sentence denotes   <0.8 25 (32.6) 4 (9.5) 0.01
T202 18506-18540 Sentence denotes  Platelet count ×109 platelets·L−1
T203 18541-18568 Sentence denotes   <100 6 (7.7) 1 (2.4) 0.42
T204 18569-18595 Sentence denotes  Creatinine level μmol·L−1
T205 18596-18623 Sentence denotes   >133 1 (1.3) 3 (7.1) 0.11
T206 18624-18640 Sentence denotes  AST level U·L−1
T207 18641-18671 Sentence denotes   >40 21 (26.9) 12 (28.6) 0.87
T208 18672-18681 Sentence denotes Treatment
T209 18682-18731 Sentence denotes  Corticosteroid therapy 44 (56.4) 10 (23.8) 0.001
T210 18732-18770 Sentence denotes  Antibiotics 73 (93.6) 30 (71.4) 0.001
T211 18771-18832 Sentence denotes  High-flow nasal canula oxygen therapy 17 (21.8) 4 (9.5) 0.13
T212 18833-18889 Sentence denotes  Noninvasive mechanical ventilation 1 (1.3) 1 (2.4) 1.00
T213 18890-18941 Sentence denotes  Invasive mechanical ventilation 1 (1.3) 0 (0) 1.00
T214 18942-18949 Sentence denotes Outcome
T215 18950-19001 Sentence denotes  Viral shedding days 22 (18–29) 28.5 (19.5–38) 0.02
T216 19002-19063 Sentence denotes  Hospital length of stay days 23 (19–27) 18.5 (13–22.5) <0.01
T217 19064-19152 Sentence denotes Data are presented as n, median (interquartile range) or n (%), unless otherwise stated.
T218 19153-19266 Sentence denotes AST: aspartate aminotransferase. #: includes congestive heart disease and coronary atherosclerotic heart disease.
T219 19267-19375 Sentence denotes FIGURE 2 Distribution of time to the initiation of lopinavir/ritonavir (LPV/r) treatment from symptom onset.
T220 19376-19703 Sentence denotes FIGURE 3 The cumulative proportions of patients with detectable SARS-CoV-2 RNA over time, by day after symptom onset, comparing patients without lopinavir/ritonavir (LPV/r) treatment with a) patients initiating LPV/r treatment <10 days from symptom onset, and b) patients initiating LPV/r treatment >10 days from symptom onset.
T221 19705-19715 Sentence denotes Discussion
T222 19716-19789 Sentence denotes Viral shedding has commonly been used as a proxy measure for infectivity.
T223 19790-19944 Sentence denotes Therefore, identification of the duration of viral shedding would be central to inform control policies and antiviral treatment in patients with COVID-19.
T224 19945-20173 Sentence denotes In the current study of 120 hospitalised non-critically ill patients with COVID-19, we have for the first time identified that older age and the lack of LPV/r treatment were independent risk factors for prolonged viral shedding.
T225 20174-20352 Sentence denotes We have also found that an initial administration of LPV/r treatment within 10 days from symptom onset, but not afterwards, could shorten the duration of SARS-CoV-2 RNA shedding.
T226 20353-20465 Sentence denotes However, we did not observe an impact of comorbidities and corticosteroid use on the duration of viral shedding.
T227 20466-20566 Sentence denotes As an emerging novel coronavirus, data on the duration of SARS-CoV-2 RNA shedding have been limited.
T228 20567-20657 Sentence denotes Our previous study reported a median duration of SARS-CoV-2 RNA shedding of 19.5 days [7].
T229 20658-20819 Sentence denotes A recent study including 191 confirmed cases showed that SARS-CoV-2 RNA was detectable for a median of 20 days in survivors and until death in non-survivors [8].
T230 20820-20928 Sentence denotes Our corresponding estimate in the current study was 23 days using throat-swab specimens for viral detection.
T231 20929-21291 Sentence denotes In addition, the median duration of SARS-CoV-2 RNA shedding did not differ between severe and general patients in the current study, which was in contrast to a study that recruited patients infected with Middle East respiratory syndrome coronavirus (MERS-CoV), in which more severely ill patients typically had higher RNA levels and more prolonged shedding [11].
T232 21292-21404 Sentence denotes Previous studies have reported that detectable SARS-CoV-2 RNA could persist until death in non-survivors [8, 9].
T233 21405-21559 Sentence denotes Whether critically ill patients have longer viral shedding compared with the generally or severely ill patients with COVID-19 needs further investigation.
T234 21560-21842 Sentence denotes Nevertheless, given a long duration of SARS-CoV-2 RNA shedding as detected by RT-PCR, a more stringent approach to infection control, such as quarantine for an extended period of time and strict droplet precautions, may be pertinent and applicable to avoid wide-spread transmission.
T235 21843-21951 Sentence denotes Our results demonstrated that older age was independently associated with prolonged SARS-CoV-2 RNA shedding.
T236 21952-22157 Sentence denotes Previous studies have shown that older age is a risk factor for SARS-CoV-2 infection and has been associated with a greater risk of development of acute respiratory distress syndrome and mortality [8, 12].
T237 22158-22278 Sentence denotes Our findings further contribute to the literature by addressing the association between age and SARS-CoV-2 RNA shedding.
T238 22279-22495 Sentence denotes One possible explanation would be that older patients typically generate less robust innate and adaptive immune responses, limiting the viral clearance, which predisposes to prolonged duration of viral shedding [13].
T239 22496-22814 Sentence denotes Of interest, a previous study of SARS-CoV has shown that the polymorphism of genes involved in innate immunity (i.e. interleukin-18, interleukin-1A and fibrinogen-like protein 2), which could be regulated in an age- and sex-dependent manner, was associated with viral load during the initial stage of the disease [14].
T240 22815-22951 Sentence denotes This highlights the importance of host genetic factors in the process of viral infections and merits further investigations in COVID-19.
T241 22952-23090 Sentence denotes Lopinavir, an HIV-1 protease inhibitor, was administered in combination with ritonavir to increase drug bioavailability of lopinavir [15].
T242 23091-23168 Sentence denotes LPV/r has been shown to be effective in patients infected with SARS-CoV [16].
T243 23169-23258 Sentence denotes LPV/r also improved clinical parameters in MERS-CoV-infected marmosets and mice [17, 18].
T244 23259-23446 Sentence denotes Our study has, for the first time, shown that the lack of LPV/r treatment was independently associated with prolonged SARS-CoV-2 RNA shedding in non-critically ill patients with COVID-19.
T245 23447-23559 Sentence denotes Administration of LPV/r treatment could shorten the duration of viral shedding compared with no LPV/r treatment.
T246 23560-23828 Sentence denotes Interestingly, subgroup analysis revealed that the early administration of LPV/r treatment within 10 days from symptom onset, but not late administration (initiated after 10 days), could shorten the duration of SARS-CoV-2 RNA shedding compared with no LPV/r treatment.
T247 23829-24109 Sentence denotes A recent randomised controlled trial showed that LPV/r treatment could not provide additional benefit, including in relation to viral shedding, beyond standard-of-care in hospitalised severely ill adult patients with COVID-19 who required a range of ventilatory support modes [9].
T248 24110-24367 Sentence denotes However, a post hoc subgroup analysis of the LPV/r treatment in the randomised controlled trial found that earlier administration of antiviral treatment could accelerate the clinical recovery and reduce the mortality, which was consistent with our findings.
T249 24368-24508 Sentence denotes Admittedly, patients recruited in the trial were in an advanced phase of infection (as evidenced by the 25% mortality in the control group).
T250 24509-24631 Sentence denotes In contrast, most patients (99.2%) in our cohort were non-critically ill patients with COVID-19, due to triage strategies.
T251 24632-24843 Sentence denotes Because LPV/r was not particularly designed to act against SARS-CoV-2, it might reasonably be anticipated that LPV/r action on SARS-CoV-2 was not as effective as neuraminidase inhibitor action on influenza [19].
T252 24844-25080 Sentence denotes The median duration of viral shedding, even in patients who received LPV/r treatment within 10 days from symptom onset, was 19 days in the current study, demonstrating that LPV/r treatment could not completely inhibit viral replication.
T253 25081-25256 Sentence denotes In this regard, earlier administration of LPV/r therapy after symptom onset, to patients who were not in the late phase of infection, may be crucial to determine the efficacy.
T254 25257-25540 Sentence denotes Nevertheless, randomised clinical trials remain crucial to test whether earlier administration of LPV/r treatment could shorten the duration of viral shedding, accelerate the clinical recovery and improve survival in patients with COVID-19, especially in non-critically ill patients.
T255 25541-25580 Sentence denotes Our investigation has some limitations.
T256 25581-25684 Sentence denotes First, the presence of SARS-CoV-2 RNA does not necessarily indicate the production of infectious virus.
T257 25685-25896 Sentence denotes Secondly, owing to triage strategies, almost all patients in our hospital were categorised as having general and severe COVID-19; therefore, extrapolating these findings to critically ill patients needs caution.
T258 25897-26111 Sentence denotes Thirdly, the estimation of the duration of SARS-CoV-2 RNA shedding was limited by the type of respiratory specimen, the frequency of respiratory specimen collection and the lack of quantitative viral RNA detection.
T259 26112-26402 Sentence denotes Fourthly, we excluded fatal cases from the final analysis because all of them had detectable SARS-CoV-2 RNA until death, and the time to death could not accurately reflect the duration of viral shedding; therefore, the association between viral shedding and mortality could be not assessed.
T260 26403-26519 Sentence denotes Finally, interpretation of our findings was limited by the sample size and the lack of genetic analysis of the host.
T261 26520-26714 Sentence denotes Further large-scale cohort studies are still needed to better define the risk factors for prolonged viral shedding, including testing the effect of corticosteroid use, in patients with COVID-19.
T262 26715-26818 Sentence denotes In summary, older age and the lack of LPV/r treatment correlate with prolonged SARS-CoV-2 RNA shedding.
T263 26819-26913 Sentence denotes Earlier administration of LPV/r treatment may shorten the duration of SARS-CoV-2 RNA shedding.
T264 26914-27047 Sentence denotes Randomised clinical trials to determine the effectiveness of LPV/r treatment in non-critically ill patients with COVID-19 are needed.
T265 27049-27071 Sentence denotes Supplementary material
T266 27072-27201 Sentence denotes Please note: supplementary material is not edited by the Editorial Office, and is uploaded as it has been supplied by the author.
T267 27202-27250 Sentence denotes Supplementary material ERJ-00799-2020.SUPPLEMENT
T268 27252-27265 Sentence denotes Shareable PDF
T269 27266-27312 Sentence denotes This one-page PDF can be shared freely online.
T270 27313-27351 Sentence denotes Shareable PDF ERJ-00799-2020.Shareable
T271 27353-27375 Sentence denotes Supplementary Material
T272 27376-27405 Sentence denotes ERJ-00799-2020.SUPPLEMENT.pdf
T273 27406-27434 Sentence denotes ERJ-00799-2020.Shareable.pdf
T274 27436-27451 Sentence denotes Acknowledgement
T275 27452-27718 Sentence denotes We thank Wei-jie Guan (State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China) for his assistance in language editing during revision.
T276 27719-27793 Sentence denotes This article has supplementary material available from erj.ersjournals.com
T277 27794-27820 Sentence denotes Author contributions: Y-H.
T278 27821-27846 Sentence denotes Gao designed the project.
T279 27847-27849 Sentence denotes D.
T280 27850-27859 Sentence denotes Yan, X-Y.
T281 27860-27872 Sentence denotes Liu and B-T.
T282 27873-27909 Sentence denotes Dan carried out the data collection.
T283 27910-27914 Sentence denotes Y-H.
T284 27915-27924 Sentence denotes Gao, Y-N.
T285 27925-27935 Sentence denotes Zhu and L.
T286 27936-27985 Sentence denotes Huang analysed the data and prepared the figures.
T287 27986-27990 Sentence denotes Y-H.
T288 27991-27998 Sentence denotes Gao, D.
T289 27999-28008 Sentence denotes Yan, Y-N.
T290 28009-28019 Sentence denotes Zhu and L.
T291 28020-28049 Sentence denotes Huang drafted the manuscript.
T292 28050-28215 Sentence denotes All the authors have revised the manuscript critically, approved the version submitted for publication and have agreed to be accountable for all aspects of the work.
T293 28216-28240 Sentence denotes Conflict of interest: D.
T294 28241-28269 Sentence denotes Yan has nothing to disclose.
T295 28270-28296 Sentence denotes Conflict of interest: X-Y.
T296 28297-28325 Sentence denotes Liu has nothing to disclose.
T297 28326-28352 Sentence denotes Conflict of interest: Y-N.
T298 28353-28381 Sentence denotes Zhu has nothing to disclose.
T299 28382-28406 Sentence denotes Conflict of interest: L.
T300 28407-28437 Sentence denotes Huang has nothing to disclose.
T301 28438-28464 Sentence denotes Conflict of interest: B-T.
T302 28465-28493 Sentence denotes Dan has nothing to disclose.
T303 28494-28520 Sentence denotes Conflict of interest: G-J.
T304 28521-28551 Sentence denotes Zhang has nothing to disclose.
T305 28552-28578 Sentence denotes Conflict of interest: Y-H.
T306 28579-28607 Sentence denotes Gao has nothing to disclose.

2_test

Id Subject Object Predicate Lexical cue
32430428-31986264-29382632 2417-2418 31986264 denotes 1
32430428-32007143-29382632 2417-2418 32007143 denotes 1
32430428-32109013-29382632 2417-2418 32109013 denotes 1
32430428-31986264-29382633 2565-2566 31986264 denotes 2
32430428-32007143-29382633 2565-2566 32007143 denotes 2
32430428-32109013-29382633 2565-2566 32109013 denotes 2
32430428-32139464-29382633 2565-2566 32139464 denotes 2
32430428-32139464-29382634 2790-2791 32139464 denotes 7
32430428-32171076-29382635 2793-2794 32171076 denotes 8
32430428-32187464-29382636 3118-3119 32187464 denotes 9
32430428-32187464-29382637 3270-3271 32187464 denotes 9
32430428-31986264-29382638 6688-6689 31986264 denotes 2
32430428-32007143-29382639 6691-6692 32007143 denotes 3
32430428-32139464-29382640 20654-20655 32139464 denotes 7
32430428-32171076-29382641 20816-20817 32171076 denotes 8
32430428-31961300-29382642 21287-21289 31961300 denotes 11
32430428-32171076-29382643 21398-21399 32171076 denotes 8
32430428-32187464-29382644 21401-21402 32187464 denotes 9
32430428-32171076-29382645 22150-22151 32171076 denotes 8
32430428-16237654-29382646 22491-22493 16237654 denotes 13
32430428-16652313-29382647 22810-22812 16652313 denotes 14
32430428-14985565-29382648 23164-23166 14985565 denotes 16
32430428-24841269-29382649 23250-23252 24841269 denotes 17
32430428-26198719-29382650 23254-23256 26198719 denotes 18
32430428-32187464-29382651 24106-24107 32187464 denotes 9
32430428-29648602-29382652 24839-24841 29648602 denotes 19

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
4 128-136 Species denotes patients Tax:9606
5 63-82 Chemical denotes lopinavir/ritonavir MESH:C558899
6 113-127 Disease denotes critically ill MESH:D016638
7 142-162 Disease denotes SARS-CoV-2 infection MESH:C000657245
12 471-518 Species denotes severe acute respiratory syndrome coronavirus 2 Tax:2697049
13 520-530 Species denotes SARS-CoV-2 Tax:2697049
14 550-569 Chemical denotes lopinavir/ritonavir MESH:C558899
15 571-576 Chemical denotes LPV/r MESH:C558899
22 679-687 Species denotes patients Tax:9606
23 783-789 Species denotes People Tax:9606
24 905-915 Species denotes SARS-CoV-2 Tax:2697049
25 937-945 Species denotes patients Tax:9606
26 961-966 Chemical denotes LPV/r MESH:C558899
27 659-678 Disease denotes SARS-CoV-2 infected MESH:C000657245
36 1125-1133 Species denotes patients Tax:9606
37 1245-1255 Species denotes SARS-CoV-2 Tax:2697049
38 1494-1504 Species denotes SARS-CoV-2 Tax:2697049
39 1519-1527 Species denotes Patients Tax:9606
40 1205-1210 Chemical denotes LPV/r MESH:C558899
41 1397-1402 Chemical denotes LPV/r MESH:C558899
42 1542-1547 Chemical denotes LPV/r MESH:C558899
43 1710-1715 Chemical denotes LPV/r MESH:C558899
50 1878-1888 Species denotes SARS-CoV-2 Tax:2697049
51 1905-1913 Species denotes patients Tax:9606
52 1817-1822 Chemical denotes LPV/r MESH:C558899
53 1982-1987 Chemical denotes LPV/r MESH:C558899
54 1919-1943 Disease denotes coronavirus disease 2019 MESH:C000657245
55 1945-1953 Disease denotes COVID-19 MESH:C000657245
60 2065-2075 Species denotes SARS-CoV-2 Tax:2697049
61 2236-2246 Species denotes SARS-CoV-2 Tax:2697049
62 2119-2138 Chemical denotes lopinavir/ritonavir MESH:C558899
63 2176-2195 Chemical denotes lopinavir/ritonavir MESH:C558899
82 2298-2345 Species denotes Severe acute respiratory syndrome coronavirus 2 Tax:2697049
83 2347-2357 Species denotes SARS-CoV-2 Tax:2697049
84 2766-2774 Species denotes patients Tax:9606
85 3094-3102 Species denotes patients Tax:9606
86 3380-3390 Species denotes SARS-CoV-2 Tax:2697049
87 3426-3434 Species denotes patients Tax:9606
88 2923-2942 Chemical denotes lopinavir/ritonavir MESH:C558899
89 2944-2949 Chemical denotes LPV/r MESH:C558899
90 3197-3202 Chemical denotes LPV/r MESH:C558899
91 3332-3337 Chemical denotes LPV/r MESH:C558899
92 3476-3481 Chemical denotes LPV/r MESH:C558899
93 2396-2405 Disease denotes mortality MESH:D003643
94 2502-2526 Disease denotes coronavirus disease 2019 MESH:C000657245
95 2528-2536 Disease denotes COVID-19 MESH:C000657245
96 2780-2788 Disease denotes COVID-19 MESH:C000657245
97 3108-3116 Disease denotes COVID-19 MESH:C000657245
98 3259-3268 Disease denotes mortality MESH:D003643
99 3411-3425 Disease denotes critically ill MESH:D016638
104 3759-3767 Species denotes patients Tax:9606
105 3674-3679 Chemical denotes LPV/r MESH:C558899
106 3744-3758 Disease denotes critically ill MESH:D016638
107 3773-3793 Disease denotes SARS-CoV-2 infection MESH:C000657245
109 3841-3853 Species denotes Participants Tax:9606
134 3912-3920 Species denotes patients Tax:9606
135 3952-3958 Species denotes People Tax:9606
136 4118-4126 Species denotes patients Tax:9606
137 4757-4765 Species denotes patients Tax:9606
138 4854-4862 Species denotes patients Tax:9606
139 5628-5635 Species denotes patient Tax:9606
140 5841-5848 Species denotes patient Tax:9606
141 6222-6228 Species denotes People Tax:9606
142 6282-6289 Species denotes patient Tax:9606
143 5076-5082 Chemical denotes oxygen MESH:D010100
144 5134-5140 Chemical denotes oxygen MESH:D010100
145 5168-5174 Chemical denotes oxygen MESH:D010100
146 5998-6003 Chemical denotes LPV/r MESH:C558899
147 4032-4040 Disease denotes COVID-19 MESH:C000657245
148 4152-4172 Disease denotes SARS-CoV-2 infection MESH:C000657245
149 4532-4541 Disease denotes Infection MESH:D007239
150 4657-4665 Disease denotes COVID-19 MESH:C000657245
151 4801-4810 Disease denotes pneumonia MESH:D011014
152 4892-4897 Disease denotes fever MESH:D005334
153 4902-4928 Disease denotes respiratory tract symptoms MESH:D012140
154 4934-4943 Disease denotes pneumonia MESH:D011014
155 5353-5372 Disease denotes respiratory failure MESH:D012131
156 5425-5430 Disease denotes shock MESH:D012769
157 5445-5458 Disease denotes organ failure MESH:D009102
166 6450-6456 Species denotes People Tax:9606
167 6782-6792 Species denotes SARS-CoV-2 Tax:2697049
168 7050-7060 Species denotes SARS-CoV-2 Tax:2697049
169 7235-7253 Chemical denotes methylprednisolone MESH:D008775
170 6382-6402 Disease denotes SARS-CoV-2 infection MESH:C000657245
171 6865-6870 Disease denotes fever MESH:D005334
172 6872-6877 Disease denotes cough MESH:D003371
173 6882-6890 Disease denotes dyspnoea MESH:D004417
175 7316-7335 Chemical denotes Lopinavir/ritonavir MESH:C558899
180 7346-7351 Chemical denotes LPV/r MESH:C558899
181 7670-7675 Chemical denotes LPV/r MESH:C558899
182 7730-7735 Chemical denotes LPV/r MESH:C558899
183 7627-7635 Disease denotes COVID-19 MESH:C000657245
194 8217-8227 Species denotes SARS-CoV-2 Tax:2697049
195 8298-8308 Species denotes SARS-CoV-2 Tax:2697049
196 8492-8502 Species denotes SARS-CoV-2 Tax:2697049
197 8989-8999 Species denotes SARS-CoV-2 Tax:2697049
198 9084-9094 Species denotes SARS-CoV-2 Tax:2697049
199 9182-9192 Species denotes SARS-CoV-2 Tax:2697049
200 8865-8870 Chemical denotes LPV/r MESH:C558899
201 8791-8799 Disease denotes diabetes MESH:D003920
202 8801-8813 Disease denotes hypertension MESH:D006973
203 8818-8833 Disease denotes cardiac disease MESH:D006331
205 9387-9394 Species denotes Patient Tax:9606
213 9534-9542 Species denotes patients Tax:9606
214 9577-9587 Species denotes SARS-CoV-2 Tax:2697049
215 9602-9610 Species denotes patients Tax:9606
216 9660-9668 Species denotes patients Tax:9606
217 9837-9845 Species denotes patients Tax:9606
218 9878-9888 Species denotes SARS-CoV-2 Tax:2697049
219 9622-9626 Disease denotes died MESH:D003643
231 10058-10066 Species denotes patients Tax:9606
232 10150-10158 Species denotes patients Tax:9606
233 10328-10336 Species denotes patients Tax:9606
234 10349-10357 Species denotes patients Tax:9606
235 10372-10379 Species denotes patient Tax:9606
236 10470-10478 Species denotes patients Tax:9606
237 10550-10555 Chemical denotes LPV/r MESH:C558899
238 10245-10257 Disease denotes hypertension MESH:D006973
239 10272-10280 Disease denotes diabetes MESH:D003920
240 10297-10312 Disease denotes cardiac disease MESH:D006331
241 10443-10451 Disease denotes COVID-19 MESH:C000657245
254 11963-11966 Gene denotes AST Gene:26503
255 10874-10882 Species denotes patients Tax:9606
256 10919-10927 Species denotes Patients Tax:9606
257 11896-11906 Chemical denotes Creatinine MESH:D003404
258 12103-12122 Chemical denotes Lopinavir/ritonavir MESH:C558899
259 11086-11098 Disease denotes Hypertension MESH:D006973
260 11135-11143 Disease denotes Diabetes MESH:D003920
261 11176-11191 Disease denotes Cardiac disease MESH:D006331
262 11223-11229 Disease denotes Stroke MESH:D020521
263 11260-11264 Disease denotes COPD MESH:D029424
264 11268-11274 Disease denotes asthma MESH:D001249
265 11298-11325 Disease denotes Chronic renal insufficiency MESH:D051436
268 10809-10817 Species denotes patients Tax:9606
269 10823-10843 Disease denotes SARS-CoV-2 infection MESH:C000657245
276 12802-12805 Gene denotes AST Gene:26503
277 12877-12885 Species denotes patients Tax:9606
278 13047-13055 Species denotes patients Tax:9606
279 13078-13086 Species denotes patients Tax:9606
280 12947-12971 Disease denotes congestive heart disease MESH:D006333
281 12976-13014 Disease denotes coronary atherosclerotic heart disease MESH:D003324
290 13156-13166 Species denotes SARS-CoV-2 Tax:2697049
291 13220-13228 Species denotes patients Tax:9606
292 13253-13263 Species denotes SARS-CoV-2 Tax:2697049
293 13398-13406 Species denotes patients Tax:9606
294 13432-13442 Species denotes SARS-CoV-2 Tax:2697049
295 13504-13512 Species denotes patients Tax:9606
296 13528-13538 Species denotes SARS-CoV-2 Tax:2697049
297 13612-13622 Species denotes SARS-CoV-2 Tax:2697049
300 13828-13836 Species denotes patients Tax:9606
301 13855-13865 Species denotes SARS-CoV-2 Tax:2697049
311 13925-13935 Species denotes SARS-CoV-2 Tax:2697049
312 14050-14058 Species denotes patients Tax:9606
313 14418-14426 Species denotes patients Tax:9606
314 14599-14609 Species denotes SARS-CoV-2 Tax:2697049
315 14926-14936 Species denotes SARS-CoV-2 Tax:2697049
316 14490-14495 Chemical denotes LPV/r MESH:C558899
317 14708-14720 Disease denotes hypertension MESH:D006973
318 14722-14730 Disease denotes diabetes MESH:D003920
319 14735-14750 Disease denotes cardiac disease MESH:D006331
324 15750-15769 Chemical denotes lopinavir/ritonavir MESH:C558899
325 15559-15571 Disease denotes Hypertension MESH:D006973
326 15595-15610 Disease denotes Cardiac disease MESH:D006331
327 15634-15642 Disease denotes Diabetes MESH:D003920
330 15185-15195 Species denotes SARS-CoV-2 Tax:2697049
331 15230-15238 Species denotes patients Tax:9606
334 15874-15884 Species denotes SARS-CoV-2 Tax:2697049
335 16068-16078 Species denotes SARS-CoV-2 Tax:2697049
337 16118-16137 Chemical denotes lopinavir/ritonavir MESH:C558899
366 16159-16167 Species denotes patients Tax:9606
367 16172-16180 Species denotes patients Tax:9606
368 16222-16230 Species denotes Patients Tax:9606
369 16354-16362 Species denotes patients Tax:9606
370 16463-16471 Species denotes patients Tax:9606
371 16810-16818 Species denotes patients Tax:9606
372 16888-16898 Species denotes SARS-CoV-2 Tax:2697049
373 17121-17129 Species denotes Patients Tax:9606
374 17218-17228 Species denotes SARS-CoV-2 Tax:2697049
375 17426-17434 Species denotes patients Tax:9606
376 17497-17505 Species denotes patients Tax:9606
377 16205-16210 Chemical denotes LPV/r MESH:C558899
378 16241-16246 Chemical denotes LPV/r MESH:C558899
379 16281-16286 Chemical denotes LPV/r MESH:C558899
380 16373-16378 Chemical denotes LPV/r MESH:C558899
381 16538-16543 Chemical denotes LPV/r MESH:C558899
382 16555-16560 Chemical denotes LPV/r MESH:C558899
383 16703-16708 Chemical denotes LPV/r MESH:C558899
384 16762-16767 Chemical denotes LPV/r MESH:C558899
385 16848-16851 Chemical denotes LRV
386 16852-16853 Chemical denotes r MESH:D001120
387 16915-16920 Chemical denotes LPV/r MESH:C558899
388 17030-17035 Chemical denotes LPV/r MESH:C558899
389 17144-17149 Chemical denotes LPV/r MESH:C558899
390 17270-17275 Chemical denotes LPV/r MESH:C558899
391 17449-17454 Chemical denotes LPV/r MESH:C558899
392 17526-17531 Chemical denotes LPV/r MESH:C558899
393 16421-16429 Disease denotes COVID-19 MESH:C000657245
406 18625-18628 Gene denotes AST Gene:26503
407 17796-17804 Species denotes Patients Tax:9606
408 17773-17778 Chemical denotes LPV/r MESH:C558899
409 17782-17787 Chemical denotes LPV/r MESH:C558899
410 18570-18580 Chemical denotes Creatinine MESH:D003404
411 17934-17949 Disease denotes Hypertension 19 MESH:C000657245
412 17973-17981 Disease denotes Diabetes MESH:D003920
413 18005-18020 Disease denotes Cardiac disease MESH:D006331
414 18044-18050 Disease denotes Stroke MESH:D020521
415 18073-18077 Disease denotes COPD MESH:D029424
416 18081-18087 Disease denotes asthma MESH:D001249
417 18110-18137 Disease denotes Chronic renal insufficiency MESH:D051436
423 17651-17659 Species denotes patients Tax:9606
424 17708-17727 Chemical denotes lopinavir/ritonavir MESH:C558899
425 17729-17734 Chemical denotes LPV/r MESH:C558899
426 17748-17753 Chemical denotes LPV/r MESH:C558899
427 17665-17685 Disease denotes SARS-CoV-2 infection MESH:C000657245
431 19153-19156 Gene denotes AST Gene:26503
432 19198-19222 Disease denotes congestive heart disease MESH:D006333
433 19227-19265 Disease denotes coronary atherosclerotic heart disease MESH:D003324
436 19318-19337 Chemical denotes lopinavir/ritonavir MESH:C558899
437 19339-19344 Chemical denotes LPV/r MESH:C558899
447 19415-19423 Species denotes patients Tax:9606
448 19440-19450 Species denotes SARS-CoV-2 Tax:2697049
449 19504-19512 Species denotes patients Tax:9606
450 19567-19575 Species denotes patients Tax:9606
451 19639-19647 Species denotes patients Tax:9606
452 19521-19540 Chemical denotes lopinavir/ritonavir MESH:C558899
453 19542-19547 Chemical denotes LPV/r MESH:C558899
454 19587-19592 Chemical denotes LPV/r MESH:C558899
455 19659-19664 Chemical denotes LPV/r MESH:C558899
464 19921-19929 Species denotes patients Tax:9606
465 20005-20013 Species denotes patients Tax:9606
466 20328-20338 Species denotes SARS-CoV-2 Tax:2697049
467 20098-20103 Chemical denotes LPV/r MESH:C558899
468 20227-20232 Chemical denotes LPV/r MESH:C558899
469 19935-19943 Disease denotes COVID-19 MESH:C000657245
470 19990-20004 Disease denotes critically ill MESH:D016638
471 20019-20027 Disease denotes COVID-19 MESH:C000657245
491 20481-20498 Species denotes novel coronavirus Tax:2697049
492 20524-20534 Species denotes SARS-CoV-2 Tax:2697049
493 20616-20626 Species denotes SARS-CoV-2 Tax:2697049
494 20715-20725 Species denotes SARS-CoV-2 Tax:2697049
495 20965-20975 Species denotes SARS-CoV-2 Tax:2697049
496 21031-21039 Species denotes patients Tax:9606
497 21110-21118 Species denotes patients Tax:9606
498 21133-21188 Species denotes Middle East respiratory syndrome coronavirus (MERS-CoV) Tax:1335626
499 21217-21225 Species denotes patients Tax:9606
500 21339-21349 Species denotes SARS-CoV-2 Tax:2697049
501 21428-21436 Species denotes patients Tax:9606
502 21508-21516 Species denotes patients Tax:9606
503 21599-21609 Species denotes SARS-CoV-2 Tax:2697049
504 20792-20797 Disease denotes death MESH:D003643
505 21119-21127 Disease denotes infected MESH:D007239
506 21374-21379 Disease denotes death MESH:D003643
507 21413-21427 Disease denotes critically ill MESH:D016638
508 21522-21530 Disease denotes COVID-19 MESH:C000657245
509 21675-21684 Disease denotes infection MESH:D007239
521 22613-22627 Gene denotes interleukin-18 Gene:3606
522 22629-22673 Gene denotes interleukin-1A and fibrinogen-like protein 2 Gene:10875
523 21927-21937 Species denotes SARS-CoV-2 Tax:2697049
524 22254-22264 Species denotes SARS-CoV-2 Tax:2697049
525 22324-22332 Species denotes patients Tax:9606
526 22529-22537 Species denotes SARS-CoV Tax:694009
527 22016-22036 Disease denotes SARS-CoV-2 infection MESH:C000657245
528 22099-22134 Disease denotes acute respiratory distress syndrome MESH:D012128
529 22139-22148 Disease denotes mortality MESH:D003643
530 22888-22904 Disease denotes viral infections MESH:D001102
531 22942-22950 Disease denotes COVID-19 MESH:C000657245
582 24794-24807 Gene denotes neuraminidase Gene:4758
583 22966-22971 Species denotes HIV-1 Tax:11676
584 23131-23139 Species denotes patients Tax:9606
585 23154-23162 Species denotes SARS-CoV Tax:694009
586 23230-23239 Species denotes marmosets Tax:38020
587 23244-23248 Species denotes mice Tax:10090
588 23377-23387 Species denotes SARS-CoV-2 Tax:2697049
589 23423-23431 Species denotes patients Tax:9606
590 23771-23781 Species denotes SARS-CoV-2 Tax:2697049
591 24032-24040 Species denotes patients Tax:9606
592 24380-24388 Species denotes patients Tax:9606
593 24527-24535 Species denotes patients Tax:9606
594 24582-24590 Species denotes patients Tax:9606
595 24691-24701 Species denotes SARS-CoV-2 Tax:2697049
596 24759-24769 Species denotes SARS-CoV-2 Tax:2697049
597 24891-24899 Species denotes patients Tax:9606
598 25161-25169 Species denotes patients Tax:9606
599 25474-25482 Species denotes patients Tax:9606
600 25531-25539 Species denotes patients Tax:9606
601 22952-22961 Chemical denotes Lopinavir MESH:D061466
602 23029-23038 Chemical denotes ritonavir MESH:D019438
603 23075-23084 Chemical denotes lopinavir MESH:D061466
604 23091-23096 Chemical denotes LPV/r MESH:C558899
605 23169-23174 Chemical denotes LPV/r MESH:C558899
606 23317-23322 Chemical denotes LPV/r MESH:C558899
607 23465-23470 Chemical denotes LPV/r MESH:C558899
608 23543-23548 Chemical denotes LPV/r MESH:C558899
609 23635-23640 Chemical denotes LPV/r MESH:C558899
610 23812-23817 Chemical denotes LPV/r MESH:C558899
611 23878-23883 Chemical denotes LPV/r MESH:C558899
612 24155-24160 Chemical denotes LPV/r MESH:C558899
613 24640-24645 Chemical denotes LPV/r MESH:C558899
614 24743-24748 Chemical denotes LPV/r MESH:C558899
615 24913-24918 Chemical denotes LPV/r MESH:C558899
616 25017-25022 Chemical denotes LPV/r MESH:C558899
617 25123-25128 Chemical denotes LPV/r MESH:C558899
618 25355-25360 Chemical denotes LPV/r MESH:C558899
619 23140-23148 Disease denotes infected MESH:D007239
620 23217-23229 Disease denotes CoV-infected MESH:D018352
621 23408-23422 Disease denotes critically ill MESH:D016638
622 23437-23445 Disease denotes COVID-19 MESH:C000657245
623 24046-24054 Disease denotes COVID-19 MESH:C000657245
624 24317-24326 Disease denotes mortality MESH:D003643
625 24441-24450 Disease denotes infection MESH:D007239
626 24476-24485 Disease denotes mortality MESH:D003643
627 24567-24581 Disease denotes critically ill MESH:D016638
628 24596-24604 Disease denotes COVID-19 MESH:C000657245
629 25204-25213 Disease denotes infection MESH:D007239
630 25488-25496 Disease denotes COVID-19 MESH:C000657245
631 25516-25530 Disease denotes critically ill MESH:D016638
644 25604-25614 Species denotes SARS-CoV-2 Tax:2697049
645 25734-25742 Species denotes patients Tax:9606
646 25873-25881 Species denotes patients Tax:9606
647 25940-25950 Species denotes SARS-CoV-2 Tax:2697049
648 26205-26215 Species denotes SARS-CoV-2 Tax:2697049
649 26691-26699 Species denotes patients Tax:9606
650 25805-25813 Disease denotes COVID-19 MESH:C000657245
651 25858-25872 Disease denotes critically ill MESH:D016638
652 26226-26231 Disease denotes death MESH:D003643
653 26249-26254 Disease denotes death MESH:D003643
654 26370-26379 Disease denotes mortality MESH:D003643
655 26705-26713 Disease denotes COVID-19 MESH:C000657245
664 26794-26804 Species denotes SARS-CoV-2 Tax:2697049
665 26889-26899 Species denotes SARS-CoV-2 Tax:2697049
666 27013-27021 Species denotes patients Tax:9606
667 26753-26758 Chemical denotes LPV/r MESH:C558899
668 26845-26850 Chemical denotes LPV/r MESH:C558899
669 26975-26980 Chemical denotes LPV/r MESH:C558899
670 26998-27012 Disease denotes critically ill MESH:D016638
671 27027-27035 Disease denotes COVID-19 MESH:C000657245
673 27873-27876 Gene denotes Dan Gene:4681
675 28465-28468 Gene denotes Dan Gene:4681

MyTest

Id Subject Object Predicate Lexical cue
32430428-31986264-29382632 2417-2418 31986264 denotes 1
32430428-32007143-29382632 2417-2418 32007143 denotes 1
32430428-32109013-29382632 2417-2418 32109013 denotes 1
32430428-31986264-29382633 2565-2566 31986264 denotes 2
32430428-32007143-29382633 2565-2566 32007143 denotes 2
32430428-32109013-29382633 2565-2566 32109013 denotes 2
32430428-32139464-29382633 2565-2566 32139464 denotes 2
32430428-32139464-29382634 2790-2791 32139464 denotes 7
32430428-32171076-29382635 2793-2794 32171076 denotes 8
32430428-32187464-29382636 3118-3119 32187464 denotes 9
32430428-32187464-29382637 3270-3271 32187464 denotes 9
32430428-31986264-29382638 6688-6689 31986264 denotes 2
32430428-32007143-29382639 6691-6692 32007143 denotes 3
32430428-32139464-29382640 20654-20655 32139464 denotes 7
32430428-32171076-29382641 20816-20817 32171076 denotes 8
32430428-31961300-29382642 21287-21289 31961300 denotes 11
32430428-32171076-29382643 21398-21399 32171076 denotes 8
32430428-32187464-29382644 21401-21402 32187464 denotes 9
32430428-32171076-29382645 22150-22151 32171076 denotes 8
32430428-16237654-29382646 22491-22493 16237654 denotes 13
32430428-16652313-29382647 22810-22812 16652313 denotes 14
32430428-14985565-29382648 23164-23166 14985565 denotes 16
32430428-24841269-29382649 23250-23252 24841269 denotes 17
32430428-26198719-29382650 23254-23256 26198719 denotes 18
32430428-32187464-29382651 24106-24107 32187464 denotes 9
32430428-29648602-29382652 24839-24841 29648602 denotes 19